Evidence map›Paper›PMID 41429602›Full record

ArticleArthritis & rheumatology (Hoboken, N.J.)2026

Per- and Polyfluoroalkyl Substances and Hand Osteoarthritis: Data From the Osteoarthritis Initiative.

Jeffrey B Driban, Lisa B Rokoff, Bing Lu, Timothy E McAlindon, Charles B Eaton, Mary B Roberts, Diana Mathes, Colleen Lestician, Zhijin Carrie Xu, Zhihua Tina Fan and 5 more

Abstract read
In one paragraph

Article in Arthritis & rheumatology (Hoboken, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jeffrey B DribanDepartment of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, Massachusetts.ORCID 0000-0001-6098-4273
Lisa B RokoffCenter for Interdisciplinary and Population Health Research, MaineHealth Institute for Research, Westbrook, Maine.
Bing LuDepartment of Public Health Sciences, UConn Health, Farmington, Connecticut.
Timothy E McAlindonDivision of Rheumatology, Department of Medicine, UMass Chan Medical School, Worcester, Massachusetts.
Charles B EatonCenter for Primary Care and Prevention, Kent Hospital, Pawtucket, Rhode Island.ORCID 0000-0002-7723-9461
Mary B RobertsCenter for Primary Care and Prevention, Kent Hospital, Pawtucket, Rhode Island.
Diana MathesEnvironmental and Chemical Laboratory Services, Public Health & Environmental Laboratories, New Jersey Department of Health, Ewing.
Colleen LesticianEnvironmental and Chemical Laboratory Services, Public Health & Environmental Laboratories, New Jersey Department of Health, Ewing.
Zhijin Carrie XuEnvironmental and Chemical Laboratory Services, Public Health & Environmental Laboratories, New Jersey Department of Health, Ewing.
Zhihua Tina FanEnvironmental and Chemical Laboratory Services, Public Health & Environmental Laboratories, New Jersey Department of Health, Ewing.
Shawn P O'LearyEnvironmental and Chemical Laboratory Services, Public Health & Environmental Laboratories, New Jersey Department of Health, Ewing.
Ida K HaugenCenter for Treatment of Rheumatic and Musculoskeletal Diseases (REMEDY), Diakonhjemmet Hospital, Oslo, Norway.ORCID 0000-0001-7810-2216
Jérémie SellamDepartment of Rheumatology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Centre de Recherche Saint-Antoine (CRSA) Inserm UMRS-938, Sorbonne Université, Paris, France.
Alice CourtiesDepartment of Rheumatology, Saint-Antoine Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Centre de Recherche Saint-Antoine (CRSA) Inserm UMRS-938, Sorbonne Université, Paris, France.
Abby F FleischCenter for Interdisciplinary and Population Health Research, MaineHealth Institute for Research, Westbrook, Maine.

Funding

Prospective associations of childhood PFAS with metabolomic profiles, pubertal timing, and bone healthR01ES030101 · NIEHS · MAINEHEALTH · PI Abby Fleisch · 2019 to 2026
$3.6M
Environmental Factors Associated with the Development of OsteoarthritisR01AR081791 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DRIBAN, JEFFREY B · 2023 to 2025
$1.7M
The OAI Collaborative Osteoarthritis Research Enterprise (OAI CORE) KnowledgebaseR24AR085006 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Jeffrey B Driban · 2025 to 2026
$1.0M
NIAMS NIH HHS R01 AR081791NIAMS NIH HHS R24 AR085006NIEHS NIH HHS R01 ES030101NIEHS NIH HHS R01 ES30101NIH HHS N01-AR-2-2258NIH HHS N01-AR-2-2259NIH HHS N01-AR-2-2260NIH HHS N01-AR-2-2261NIH HHS N01-AR-2-2262
6 · The paper itself

Abstract

objectiveTo explore whether biologic levels of specific per- and polyfluoroalkyl substances (PFAS) and a mixture of PFAS-reflecting the overall effect and accounting for correlations among PFAS-relate to incident hand osteoarthritis (HOA) and progression.

methodsAmong a case-cohort sample from the Osteoarthritis Initiative (n = 1,878), we examined associations of eight PFAS in serum with odds of developing over the subsequent 4 years (1) symptomatic HOA and (2) an increased number of joints with radiographic osteoarthritis (Kellgren-Lawrence ≥2; yes/no). We used weighted logistic regression to assess single PFAS (continuous and quartiles) and quantile g-computation to assess the PFAS mixture in relation to our primary outcomes.

resultsParticipants were primarily female (58%) and on average aged 62 years and overweight (mean body mass index = 28.6 kg/m

conclusionWe observed possible associations of PFDA and PFNA serum concentrations with symptomatic HOA incidence, but we otherwise found no consistent evidence that greater PFAS concentrations relate to a greater chance of developing HOA incidence or progression.

Indexed as

FluorocarbonsHand JointsOsteoarthritisAgedAlkanesulfonic AcidsCase-Control StudiesDecanoic AcidsDisease ProgressionFemaleHumansIncidenceLogistic ModelsMaleMiddle AgedAlkanesulfonic AcidsDecanoic AcidsFluorocarbonsperflexaneperfluorodecanoic acid

Identifiers

PMID41429602
PMCPMC12917737

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.